Medtronic Takes Next Step As Heart-Failure Service Provider
This article was originally published in The Gray Sheet
The firm signaled its plan three years ago to transform itself into more of a services partner for hospitals than a product supplier. It took the latest step in that direction with the launch of service for heart-failure management, combing data from its cardiac rhythm management devices and its remote-monitoring offerings.
You may also be interested in...
The deal gives Medtronic its first ventricular-assist devices and gives struggling HeartWare a needed boost.
Medtronic hopes the $200 million purchase of telehealth firm Cardiocom will enhance its ability to respond to increasing demands on hospitals to better manage patient outcomes and costs. It will also greatly expand its customer base.
News We’re Watching: Free COVID-19 Tests, Edwards Antitrust Investigation, McKinsey Calls For Medtech ‘Reinvention’
This week, the US government relaunched a program providing free COVID-19 tests and invested $600m in domestic test manufacturing; the European Commission revealed an antitrust investigation of Edwards LifeSciences; and a consulting firm report said the medtech industry should make big changes to address investor skepticism.